RESUMEN
Multi-cavity mold design is an efficient approach to achieving mass production and is frequently used in plastic injection applications. The runner system of a multi-cavity mold delivers molten plastic to each cavity evenly and makes the molded product from each individual cavity possess an equivalent quality. Not only the dimensions, but also the invisible quality, e.g., the internal stress of the product is of great concern in regard to molding quality. Using commercial software to find an optimal solution for the runner system may be time-consuming in respect to iterations if the engineers lack empirical rules. The H-type runner system is often used due to an inherently balanced filling in multi-cavities. However, the shear heat inducing an imbalanced flow behavior requires the H-type runner system to be improved as the number of the cavities is increased. This work develops a methodology based on the rheological concept to determine the runner system of a multi-cavity mold semi-analytically. As the relation of the viscosity with respect to shear rate is known, the runner system can be constructed step-by-step via this method. The use of the proposed method helps to focus attention on the connection between the physical situation and its related mathematical model. The influences of the melt temperature and resin type can be easily investigated. Three design examples, a 16-cavity mold with a fishbone runner system, an 8-cavity mold with an arbitrary runner layout, and the influences of melt temperature and resin type on the runner design are demonstrated and validated by the commercial software. The proposed method shows its great benefit when a new runner design project is launched in the initial design stage and then cooperates with the commercial software for further modifications.
RESUMEN
To estimate the effect of bisphosphine ligands on the formation of the isomeric core structures of gold nanoclusters, the different ligation of bisphosphine ligands is usually used to participate in the construction of gold nanoclusters. Here, the selection of the different bisphosphine ligands, DPEphos and Xantphos, is performed to construct two novel gold nanoclusters, [Au11(DPEphos)4Cl2]Cl (1) and [Au11(Xantphos)4Cl2]Cl(2), which have been characterized by IR, 1H and 31P NMR, ESI-MS, XRD, SEM, XPS, TG, UV-vis, and X-ray crystal structure analysis. The structural analyses indicate that the ligation of bisphosphine ligands play a crucial role in the formation of the fascinating Au11 cores: gold nanocluster 1 includes a birdcage-shaped Au11 core with eight electrons, while gold nanocluster 2 contains a crown-shaped Au11 core with eight electrons. Meanwhile, DOS and PDOS studies indicate that the Au11 cores have a strong effect on the composition of HOMO and LUMO orbitals of gold nanoclusters. Furthermore, the different Au11 core structures lead to different optical absorption characteristics (1: 456 nm; 2: 427 nm). All these demonstrate that the ligation of bisphosphine ligands may have an important influence on constructing the stability of the isomeric core structures of gold nanoclusters.
RESUMEN
B-32 is one of a panel of monoclonal anti-idiotypic antibodies to growth hormone (GH) that we developed. To characterize and identify its potential role as a novel growth hormone receptor (GHR) agonist, we determined that B-32 behaved as a typical Ab2ß based on a series of enzyme-linked immunosorbent assay assays. The results of fluorescence-activated cell sorting, indirect immunofluorescence and competitive receptor binding assays demonstrated that B-32 specifically binds to the GHR expressed on target cells. Next, we examined the resulting signal transduction pathways triggered by this antibody in primary porcine hepatocytes. We found that B-32 can activate the GHR and Janus kinase (2)/signal transducers and activators of transcription (JAK2/STAT5) signalling pathways. The phosphorylation kinetics of JAK2/STAT5 induced by either GH or B-32 were analysed in dose-response and time course experiments. In addition, B32 could also stimulate porcine hepatocytes to secrete insulin-like growth factors-1. Our work indicates that a monoclonal anti-idiotypic antibody to GH (B-32) can serve as a GHR agonist or GH mimic and has application potential in domestic animal (pig) production.